Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
IsraelIPO:
15 October 2010Website:
http://www.evogene.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 20:18:38 GMTDividend
Analysts recommendations
Institutional Ownership
EVGN Latest News
Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd.
Current castor seed production is expected to support the supply of the new order in 2024, valued at ~ $440K REHOVOT, Israel , June 25, 2024 /PRNewswire/ -- Casterra Ag Ltd ., a subsidiary of Evogene Ltd.
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024.
Evogene (EVGN) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.07 per share a year ago.
Does Evogene (EVGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Evogene Ltd. (NASDAQ:EVGN ) Q3 2023 Earnings Conference Call November 15, 2023 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Amit Noam - Chief Executive Officer of Lavie Bio Nir Arbel - CPO of Evogene Conference Call Participants Ryan Mayer - Lake Street Capital Brian Wright - ROTH Capital Benjamin Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by.
Evogene (EVGN) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.21 per share a year ago.
Evogene's wholly-owned subsidiary Casterra Ag has received initial purchase orders worth $11.3 million for its proprietary castor plant seeds, which will be used for biofuel production in Africa. The orders come earlier than expected, as Evogene's CEO previously anticipated seed sales to begin in 2024. Castor oil is increasingly seen as a green biofuel in Europe, with EU regulations requiring 14% of transportation fuels to be biofuels by 2030.
Evogene Ltd (NASDAQ:EVGN ) Q1 2023 Earnings Conference Call May 18, 2023 9:00 AM ET Company Participants Rachel Tamara - Evident, Head of Investor Relations Ofer Haviv - CEO & President Nir Arbel - Chief Product Officer Elran Haber - CEO, Biomica Ltd Yaron Eldad - CFO Conference Call Participants Brian Wright - ROTH MKM Ben Klieve - Lake Street Capital Markets Brett Reiss - Janney Montgomery Scott Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's First Quarter 2023 Results Conference Call.
What type of business is Evogene?
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
What sector is Evogene in?
Evogene is in the Healthcare sector
What industry is Evogene in?
Evogene is in the Biotechnology industry
What country is Evogene from?
Evogene is headquartered in Israel
When did Evogene go public?
Evogene initial public offering (IPO) was on 15 October 2010
What is Evogene website?
https://www.evogene.com
Is Evogene in the S&P 500?
No, Evogene is not included in the S&P 500 index
Is Evogene in the NASDAQ 100?
No, Evogene is not included in the NASDAQ 100 index
Is Evogene in the Dow Jones?
No, Evogene is not included in the Dow Jones index
When does Evogene report earnings?
Next earnings report date is not announced yet